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ABSTRACT 
Objective: The current plan was accompanied to explicate the possible protective role of vanillic acid (VA), on modification in lipid peroxidation, 
inflammatory cytokines, membrane-bound enzymes, and glycoconjugates during B(a)P induced lung cancer in Swiss albino mice.  
Methods: Benzo(a)pyrene was administered orally (50 mg/kg b. wt) to induce lung cancer in Swiss albino mice. lipid peroxidation, serum marker 
enzymes, inflammatory cytokines, membrane-bound ATPases and protein-bound carbohydrate components (Hexose, hexosamine, sialic acid and 
fucose) and Mast cells and PAS staining were carried out.  
Results: Lung cancer possessing animals exhibited increased levels of lipid peroxidation, ADA, AHH, γ-GT, 5’-NT, LDH, cytokines such as TNF-α and 
IL-1β, protein-bound carbohydrate components (protein-hexose, hexosamine, sialic acid, and fucose) also diminished activity of membrane-bound 
ATPases (Na+/K+ATPases, Ca2+ATPases, and Mg2+
Conclusion: Overall, the present study evidence to the VA has effective anti-inflammatory in addition to free radical scavenging activity for the 
duration of lung carcinogenesis in Swiss albino mice. 
ATPase). Treatment with VA significantly ameliorated all these activities.  
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INTRODUCTION 
Lung malignancy is one of the most generally diagnosed cancers 
worldwide, it also ranks first as a foremost cause of cancer-related 
deaths both men and women [1]. Around 90% of all lung cancer is 
instigated through cigarette smoking [2, 3]. Oxidative stress-
mediated lipid peroxidation (LPO) acting a substantial part of 
carcinogenesis and most studied relevant to the free radical chain 
reaction. Glycoproteins are the main constituents of the cell 
membrane which act as a significant part of cell differentiation, cell 
proliferation, and cell-cell interaction [4, 5]. Chemoprevention deals 
with a unique approach to regulate the incidence and mortality of 
lung malignancy [6]. In modern years, significant consideration was 
given to increase in dietetic consumption of phytochemicals because 
epidemiological, as well as experimental studies, gave an optimistic 
association between reduced risks of cancer due to intake of 
phytochemicals [7]. 
Vanillic acid (VA) is dietetic phenolic derivative natural substances 
found in vanilla bean and benzoin [8]. It is also found in wine and 
vinegar [9)]. VA eliminates the ROS as well as hydroxyl radicals and 
lipid peroxide radicals and also protects the biological membrane by 
inhibiting lipid peroxidation [10, 11] It possesses antioxidant activity 
[10)], anti-genotoxic [12]. VA has been connected with abundant 
pharmacological possessions to treat carcinogenesis [13, 14], 
apoptosis [15], and hepatoprotective effects [16]. VA also exhibits a 
chemopreventive effect in experimentally induced carcinogenesis in 
rats [17, 18]. Recently, we have stated the antioxidant and anticancer 
potential of VA during experimentally induced lung cancer [19].  
The current plan was designed to focus the defensive effect of VA on 
the expression of inflammatory cytokines together with the lipid 
peroxidation, membrane-bound enzymes, and cell surface 
abnormalities by assessing the glycoconjugates levels during B(a)P 
induced lung cancer in albino mice.  
MATERIALS AND METHODS 
Chemicals 
Benzo(a)pyrene, vanillic acid, BSA were bought from Sigma 
chemicals, St Louis, USA. The primary and secondary antibodies 
obtained from Santa Cruz Biotech, USA. The other chemicals were 
procured of analytical grade from SRL Chemicals Pvt, Ltd, Mumbai, 
India. TNF-α, IL-1β enzyme-linked immunosorbent assay (ELISA) 
kits were obtained from Thermo Fisher Scientific.  
Experimental proposal 
All the experiments were considered and carried out according to 
the Institutional Animal Ethical Committee agreed guidelines (IAEC 
No.01/05/2018). Healthy male mice obtained from the veterinary 
college (Tanuvas), Chennai. The animals maintained in perfect, 
sanitized confines at (25±2 °C) then were adjusted to the 12-h bright 
and dusky cycles. Animals were fed with commercially available rat 
pellet feed (Hindustan Foods Ltd, Bangalore, India).  
Mice were randomly dispersed into four groups; each group 
contains 6 animals, groups classified as follows:  
Group I served as control animals and was given corn oil orally for 16 w 
along with diet and drinking water. Group 2 animals were administered 
with B(a)P (50 mg/kg b. wt.) disbanded in corn oil orally twice a week 
for 4 subsequent weeks and remain for 16 w. Group 3 animals were 
treated with of VA (200 mg/kg b. wt.) alternate days a week orally for 16 
w along with B(a)P. VA treatment was started one week earlier than to 
the beginning dosage of B(a)P administration and continued until the 
end of the experimental period. Group 4 animals were treated with of VA 
(200 mg/kg b. wt.) alternating days a week orally for 16 w. At the end of 
the experimental period, the animals were fasted throughout the night, 
anesthetized followed by cervical decapitation. The serum and 
supernatants were collected for evaluating different parameters. The 
protein was assessed in serum and tissue homogenate by the method 
[20]. Serum marker enzymes Adenosine deaminase (ADA) [21], AHH 
[22], γ-Glutamyl transpeptidase (γ-GT) [23], 5’-nucleotidase (5’-NT) [24], 
and lactate dehydrogenase (LDH) [25] were assayed. Erythrocyte 
membranes were isolated according to the standard protocol by the 
method [26] and LPO was evaluated according to [27]. 
Determination of membrane-bound enzymes and Glycoprotein’s 
The activity of Na+/K+ATPase by [28] Ca2+ATPase by [29] as well as 
Mg2+ATPase by [30] was estimated. Hexose, hexosamine, and fucose 
determination by [31]. Sialic acid was determined by the method [32]. 
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Inflammatory cytokines ELISA 
Serum TNF-α and IL-1β levels were measured by ELISA kits 
according to the manufacturer’s protocol. 
Mast cell and PAS staining 
Mast cell staining investigation was performed by the standard 
procedure [33]. PAS staining investigation was performed by the 
standard procedure [34]. 
Western blot analysis of inflammatory cytokines 
Western blot investigation of inflammatory cytokines (TNF-α, IL-1β) 
was performed by the standard procedure [35]. Densitometry data 
are denoted in bar graphs as ‘fold change’ equalled to control.  
Statistical analysis 
The data were analyzed by using SPSS/10 software. Data were 
assessed by one-way analysis of variance (ANOVA) followed by least 
significance difference (LSD) test. P<0.05 were considered to 
indicate statistical significance. The entire outcomes were expressed 
as a mean±standard error (SE) for six animals in all groups. 
RESULTS 
VA inhibits lipid peroxidation (LPO) in the lung and erythrocyte 
membrane of control and experimental animals 
Fig. 1a shows the B(a)P induced group II animals, there was a 
considerable increase in the levels of lung and erythrocyte 
membrane lipid peroxides while compared with group I animals. 
Whereas VA treated group III animals, there is a substantial 
reduction in the altitudes of lipid peroxides while compared to 
group II animals. However, there were no noticeable changes 
observed in group IV animals while compared to group I animals. 
VA decreased the levels of serum marker enzymes in 
experimental conditions 
Fig. 2 represents the effect of VA on the levels of serum marker 
enzymes in control and experimental animals. Serum marker 
enzymes ADA, AHH, γ-GT, 5’-NT and LDH were found to be 
noticeably elevated in cancer possessing group II animals. On VA 
(Group III) treatment, the levels of these enzymes were 
considerably retained to near normal level while compared to 
group II animals. 
  
 
Fig. 1a: Levels of malondialdehyde (MDA) in lung and erythrocyte membrane, (fig. 1b) Levels of glycoconjugates, and (fig. 1c) Erythrocyte 
membrane ATPases activity in control and experimental animals, Results are expressed as mean±S. D for six animals in each group. 
Results are given as statistically significant at *p<0.05; aas compared with Group I; b as compared with Group II; ns: non-significant as 
compared to control. Units were expressed as mmol of MDA formed/min/mg of protein. Mg/ml. nmol of pi formed/min/mg protein 
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Fig. 2(a) and (b): Levels of serum marker enzymes in the control in the control and experimental group of animals, Results are expressed 
as mean±S. D for six animals in each group. Results are given as statistically significant at *p<0.05; a as compared with Group I; b as 
compared with Group II; ns: non-significant as compared to control. Units: ADA–micro-moles of NH3
 
 liberated/mg protein/hr.; AHH–
micromoles of fluorescent phenolic metabolites formed/min/mg protein; γ-GT–nano-moles of p-nitroaniline formed/min/mg/protein; 
5’-NT–nanomoles of Pi liberated/min/mg protein; LDH–micro-moles of pyruvate liberated/min/mg protein 
 
Fig. 3: Histochemical analysis of mast cells by toluidine blue staining and PAS staining in the lung of control and experimental animals 
(10X), fig. 3 (a) shows the section from control mice lung exhibits normal architecture with minimal mast cells. (b) Section from B(a)P 
induced mice lung showing an abnormally increased number of mast cell density (c) section from VA treated mice lung showing a 
reduced number of mast cell density and infiltration. (d) Section from drug control mice lung showing normal architecture as similar to 
that of normal control lung. Violet color arrows indicate positively stained mast cells. (e) Represents the average bar graph of the total 
number of mast cells in ten different fields/slides in control and experimental groups. The data expressed as mean±SD for six mice in 
each group. Statistically significant at *p<0.05; aas compared with Group I; b as compared with Group II; ns: 
 
VA treatment reduced the mast cell infiltration  
Fig. 3 (a to d) shows the toluidine blue staining of control and 
experimental animals. Tumor possessing animals of group II showed 
the increased number of mast cells while compared to control 
animals. Whereas, VA treated animals revealed a substantial 
decrease in the number of mast cells while compared to cancer 
possessing animals. VA alone treated animals did not show any 
significant change when compared to control animals. 
VA reduces the levels of inflammatory cytokines 
non-significant as compared to 
control. Fig. 3 (f) Control group shows normal glycoconjugate expression. (g) B(a)P induced lung cancer-bearing mice lung section (Black 
arrow) indicates overexpression of glycoconjugates. (h) Decreased expression of glycoconjugates in VA+B(a)P treated animals. (i) The 
Drug control group shows normal glycoconjugates expression as compared to the control group 
Fig. 4 a, b and c depict the levels of TNF-α and IL-1β was markedly 
increased tumor possessing animals when compared to control 
animals. Whereas VA treated animals, revealed significantly reduced 
the protein expression of TNF-α and IL-1β when compared to lung 
cancer possessing animals. 
Effect of VA administration on the activity of lung and 
erythrocyte ATPases in the control and experimental animals 
Table 1, fig. 1b respectively shown the lung and erythrocyte 
ATPases, such as Na+/K+ATPase, Mg2+ATPase, as well as 
Ca2+ATPase of control and experimental animals. Noticeable 
significant decrease in the levels of Na+/K+ ATPase, Mg2+ATPase, 
and Ca2+ATPase was perceived in group II cancer possessing 
animals while compared to group I animals. Treatment of VA with 
B(a)P mice normalized the levels of lung and erythrocyte ATPases in 
group III animals. However, there were no significant changes in 
group IV animals while compared to control animals. 
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Fig. 4a and b: Effect of VA on TNF-α and IL-1β ELISA and fig. (4c) Immunoblot expression levels in experimental groups of animals, results 
are expressed as mean±S. D for six animals in each group. Results are given as statistically significant at *p<0.05; a as compared with 
Group I; b as compared with Group II; ns: 
 
non-significant as compared to control. Fig. (4d) Quantitative data stating the equivalent protein 
levels were assessed using densitometry and is uttered as “fold change” as compared with control. Units were expressed as pg/ml 
Table 1: Effect of VA administration on the activity of ATPases of lung tissue in the control and experimental groups 
Particulars Group Icontrol Group IIB(a)P Group IIIVA+B(a)P Group IVVA 
Na+/K+ATPase 6.22±0.26 3.33±0.32 4.53±0.39*a 6.05±0.23*b ns 
Mg 2+ 10.98±0.4 ATPase 6.76±0.49 7.83±0.44*a 10.87±0.41*b ns
Ca 
  
2+ 9.62±0.31 ATPase 4.86±0.44 6.51±0.59*a 9.46±0.35*b ns  
Results are expressed as mean±SD for six animals in each group. Results are given as statistically significant at *p<0.05; a as compared with Group I; 
b as compared with Group II; ns: non-significant as compared to control. Units: Na+/K+ATPase, Mg 2+ATPase and Ca 2+
 
Effect of VA administration on cell surface glycoconjugates 
abnormalities  
ATPase are expressed 
micromole (µmol) of inorganic phosphate formed/min (mg/protein). 
Fig. 1c, table 2 shows the levels of glycoconjugates (Protein-bound 
hexose, hexosamine, total sialic acid, then fucose) in the serum and 
lung tissues respectively. The levels of glycoconjugates in the serum 
and lung tissue significantly increased in administered with B(a)P 
animals while compared to control animals. Oral administration of 
VA+B(a)P treated mice brought back the levels of the 
glycoconjugates to a nearer normal level. No significant difference 
was noticed in the levels of serum and lung glycoconjugates in VA 
alone group animals while compared with control animals. Fig. 3 (f 
to i) shows the PAS staining analysis also confirms the VA treatment 
during B(a)P administration. 
 
Table 2: Effect of VA on glycoproteins like hexose, hexosamine, total sialic acid and fucose of lung tissue in the control and experimental 
animals 
Particulars Group Icontrol Group IIB(a)P Group IIIVA+B(a)P Group IVVA 
Hexose 85.41±3.45 109.65±9.27 97.32±7.08*a 84.92±3.26*b ns  
Hexosamine 38.6±1.98 67.2±6.91 53.61±5.22*a 39.1±1.78*b ns
Total sialic acid 
  
15.72±1.08 28.56±3.78 22.45±2.07*a 16.02±1.12*b 
Fucose 
ns 
13.3±1.21 21.26±2.78 18.5±2.16*a 13.63±1.29*b ns  
Results are expressed as mean±SD for six animals in each group. Results are given as statistically significant at *p<0.05; a as compared with Group I; 
b as compared with Group II; ns: 
 
non-significant as compared to control. Units: hexose, hexosamine, total sialic acid, and fucose units are expressed 
mg/g tissue protein. 
DISCUSSION 
During malignancy, the cell membrane plays a crucial role in the 
control of cell adhesiveness, cell death, as well as cell proliferation. 
Lipid peroxidation generally takes place fewer in normal 
physiological circumstances. The B(a)P is a very effective carcinogen 
with an ability to induce enormous amounts of free radicals 
generation, which in turn reacts with lipids causing LPO. In nature, 
there is a dynamic balance the number of free radicals generated in 
the body and antioxidant defense systems that reduce or scavenging 
them and protect the body against their adverse effects [36]. In the 
existing study, it is evident that an increased level of LPO was 
established in cancer possessing animals. However, the 
administration of VA decreased the LPO, which may be due to the 
free radical scavenging movement [19, 37]. 
ADA is an essential enzyme in purine metabolism as it catalyzes the 
translation reaction of adenosine to inosine [38]. AHH metabolizes 
some of the polycyclic hydrocarbons to phenols, dihydrodiols, 
quinines, and epoxides [22]. High levels of AHH were established in 
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pulmonary in the serum and tissues of animals exposed to B(a)P [39]. 
GGT activity assists as a specific marker of the prediction of the 
carcinogenic process [40]. 5’-NT are enzymes that hydrolyze 
nucleotides with a phosphate group on carbon atom 5 of ribose. 
Increased activities of 5’-NT in tumorous animals appear to have 
originated from the proliferating tumor cells [41, 42]. LDH is a fairly 
sensitive marker for solid neoplasms, also raised activity of the 
enzyme was designated in the serum of patients with lung cancer [43]. 
In the existing study, there was a substantial elevation in the levels of 
these enzymes in cancer possessing animals. VA treatment bought 
down the levels of these marker enzymes close to normal level shows 
that VA possesses defensive agents against carcinogenesis.  
The inflammatory microenvironment of cancerous tissue is 
distinguished by the occurrence of host leukocytes both in the 
supportive stroma and between tumor cells, with macrophages, 
dendritic cells, T cells, and MCs [44]. Mast cells can secrete 
numerous proangiogenic factors, which can start the tumor 
angiogenesis switch and they have been shown to store in tissues 
undergoing angiogenesis through tumor progression [45]. The 
increased mast cells were related to reduce survival rates in patients 
through pulmonary adenocarcinoma [46]. VA supplementation 
animals exhibited significantly diminished in the mast cell density 
proves its chemopreventive nature.  
Acute inflammation generated by exogenous administration of TNF-
α and IL-1β has been known under certain malignancy and 
metastasis [47]. TNF-α is predominately activated by macrophages 
and induces the variability of cellular response including apoptosis 
[48]. TNF-α has several possessions including lysis, hemorrhagic 
necrosis of tumor cells, and tissue destruction through adhesive 
molecules [49], which may stimulate the growth of fibroblasts and 
certain tumor cells [50]. IL-1β is a significant pro-inflammatory 
cytokine connected with chronic inflammation and is radically 
elevated in the levels of adenocarcinoma patient’s serum [51, 52].  
The membrane protection is in need during the treatment of adverse 
conditions of the disease progression [53]. The membrane-bound 
enzymes such as Na+/K+ATPases, Mg2+ATPase, and Ca2+ATPase are 
liable for the transport of sodium/potassium, magnesium and 
calcium ions transversely on the cell membranes at the outflow of 
ATP by way of hydrolysis. Na+/K+ATPase movement is liable for a 
large part of the energy spending which constituents the essential 
metabolic enzyme activity and the changes in the membrane 
dynamic lead to pathological conditions [4, 5, 54]. Ca2+ATPase is a 
reflection of energy-dependent calcium transport across the cell 
membrane less deformable. Mg2+
Glycoproteins exert a significant part in contributing to the surface 
properties, tumorigenesis, and as mediators of immunological 
specificity. Malignant transformation is frequently associated with 
molecular variations such as glycoproteins and glycolipids. 
Increased levels of tissue and serum glycoprotein’s hexose, 
hexosamine, sialic acid, and fucose during malignancy reflect 
moreover a local or systemic tissue response of the tumor [55]. 
Evidence from animal experimentation recommends that the 
presence of malignant tumors invoke the rise in the synthesis of 
glycoproteins, which subsequently enter into the circulation [56, 
57]. These results were also agreed with our present examination 
from which we noticed an increased level of tissue glycoconjugates 
in lung cancer-induced animals. VA treatment considerably reduces 
the level of these glycoproteins to a near-normal state. These 
decreases in the levels of glycoprotein components signify that the 
VA can restrain malignancy by modulating cellular transformation to 
protect the cell wall abnormalities. 
ATPase, along with the other 
ATPase is also involved in energy-requiring processes in the cell. 
The protective effect of VA in this system could be either due to 
scavenging peroxides before attacking the membrane and or due to 
blocking the oxidation of membrane lipids.  
CONCLUSION 
Our present investigation indicates that VA supplementation 
improved the levels of the inflammatory cytokines TNF-α, IL-1β 
protein expression, disruptions in lipid peroxidation and membrane-
bound enzyme activity, as well as glycoprotein levels during B(a)P 
induced lung cancer, thus confirms its chemopreventive effect. From 
all the above results, we conclude that the VA has a potential anti-
inflammatory, chemotherapeutic agent against B(a)P induced lung 
carcinogenesis in Swiss albino mice. 
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